Molecular Analysis Of Leukocyte Activation By Chemoattractants
Molecular Analysis Of Leukocyte Activation By Chemoattractants
批准号:
7964315
负责人:
Philip Murphy
金额:
$404.97万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AIDS/HIV problemAdhesionsAffectAmericanAreaAtherosclerosisBiologicalBloodBlood DonationsCCR1 geneCCR5 geneCell AdhesionCell surfaceCellsCellular biologyChemotactic FactorsChemotaxisCholesterolDataDiseaseDisease AssociationDisease modelEpidemicEpidemiologyFamilyFlavivirus InfectionsGene FamilyGenesGeneticGenetic PolymorphismGenomicsGenotypeGoalsHIVHealth ProfessionalHerpesviridaeHigh Density LipoproteinsHomologous GeneHumanIndividualInfectionInfiltrationInflammatoryInjuryInterferon Type IKidneyKnockout MiceLeukocytesLinkLipidsMediatingMethodsMolecularMolecular AnalysisMolecular BiologyMusMutationPathogenesisPatientsPharmaceutical PreparationsPhenotypePoxviridaePredispositionProcessPropertyProteinsReceptor GeneRed CrossReperfusion InjuryReportingResearchRiskRisk FactorsRoleSamplingScreening procedureSignal TransductionSiteStructureSymptomsSystemTestingTissuesTranslatingVirusVirus DiseasesWest Nile virusWild Type MouseWorkWound Healingbasechemokinechemokine receptorcohortfMet-Leu-Phe receptorgenetic risk factorhuman diseaseinjuredinsightleukocyte activationloss of function mutationmacrophagemanmembermigrationneutrophilnew therapeutic targetprogramsreceptorrenal ischemiauptakevirus pathogenesis
中文摘要
本项目的目的是确定血液白细胞迁移到炎症或感染的特定组织部位的分子机制和生物学背景。我们关注的是介导这一过程的化学引诱蛋白,并已经确定了部署在白细胞细胞表面的化学引诱受体大家族的成员。我们还发现了由病毒(包括疱疹病毒、痘病毒和艾滋病毒)制造的多种化学引诱剂和化学引诱剂受体模拟物的成员。我们将基因组学、分子生物学、细胞生物学和流行病学作为分析这些分子的主要方法。一个主要目标是确定个体化学引诱剂和化学引诱剂受体的特定疾病关联,以确定潜在的新治疗靶点。一个关键的策略是分析疾病模型中基因敲除小鼠的表型,以及人类疾病队列中相应人类基因功能突变丧失的关联。在2009财年,我们报告了以下三种疾病的发现:西尼罗病毒发病机制;2. 动脉粥样硬化;3)肾缺血再灌注损伤。
英文摘要
The aim of this project is to define the molecular mechanisms and biological contexts for blood leukocyte migration to specific tissue sites that are inflamed or infected. We have focused on chemoattractant proteins that mediate this process and have identified members of a large family of chemoattractant receptors that are deployed on the leukocyte cell surface. We have also identified members of a diverse group of chemoattractant and chemoattractant receptor mimics made by viruses, including herpesviruses, poxviruses and HIV. We use genomics, molecular biology, cell biology and epidemiology as the principle methods for analyzing these molecules. A major goal is to identify specific disease associations of individual chemoattractant and chemoattractant receptors, in order to identify potential new therapeutic targets. A key strategy is to analyze phenotypes of gene knockout mice in disease models as well as associations of loss of function mutations in the corresponding human genes in human disease cohorts. In FY09 we reported discoveries in the following three diseases: 1. West Nile virus pathogenesis; 2. atherosclerosis; and 3.) renal ischemia-reperfusion injury.
1.) We found that among healthy individuals donating blood, homozygous mutation CCR5D32 is a risk factor for symptoms associated with WNV infection but not for infection per se. This extends our previous work in this area that identified this genotype as a risk factor for symptomatic WNV infection in patients presenting with symptomatic illness to a health care professional. The new study was based on comprehensive WNV testing of 35 million blood donations by the American Red Cross from the start of the screening program through July, 2008. The recent work is important because it provides new insight into the mechanism by which CCR5 deficiency increases risk of symptomatic WNV disease. The WNV work is particularly challenging because this is an ongoing emerging epidemic in which it is difficult to obtain useful samples. The overall results are scientifically important because they identify the first genetic risk factor for WNV disease and the first beneficial role in humans for CCR5. The significance extends beyond WNV to HIV/AIDS since CCR5 is exploited by HIV to enter target cells and since CCR5 antagonists are now being used in patients with HIV/AIDS. The new data suggest that blocking CCR5 with a drug may increase the risk of symptomatic WNV disease should treated patients become infected with WNV.
2.) In FY09 we reported that functional polymorphism in the gene encoding human OAS1 is a risk factor for infection with West Nile virus. This result translates to human previous data associating mouse OAS1b, the homologue of human OAS1, with susceptibility to flavivirus infection. The work is scientifically important because it provides some of the first data supporting a role for the endogenous Type I interferon signaling system, which includes OAS1, in control of a viral infection in man.
3.) In FY09 we reported that atherogenic lipids can induce high-density lipoprotein uptake and cholesterol efflux in human macrophages by up-regulating transmembrane chemokine CXCL16 without engaging CXCL16-dependent cell adhesion. CXCL16 is an unusual chemokine in that it has three distinct functions: adhesion, chemotaxis and scavenging. The scientific significance of this work is that it provides an explanation for genetic evidence linking CXCL16 to protection from atherosclerosis in mouse and man.
4.) In FY09 we reported the chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury. We found that CCR1 deficient mice had markedly reduced levels of neutrophils and macrophages in the injured kidney, yet this did not affect function, which declined at the same rate as in injured kidney from wild type mice. The data suggest that CCR1 dependent cell infiltration may be more important for tissue repair than for injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOLECULAR ANALYSIS OF NEUTROPHIL ACTIVATION BY CHEMOATTRACTANTS
-
批准号:6098987
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
Molecular Analysis Of Neutrophil Activation By Chemoattr
-
批准号:6663609
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
Molecular Analysis Of Leukocyte Activation By Chemoattractants
-
批准号:8336082
-
项目类别:
-
资助金额:$257.39万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
Immunopathogenesis of SARS-CoV-2 infection
-
批准号:10927955
-
项目类别:
-
资助金额:$3.82万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
Molecular Analysis Of Leukocyte Activation By Chemoattractants
-
批准号:9354720
-
项目类别:
-
资助金额:$302.12万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
Functions and Mechanisms of NF-kB Factors and their Regulators
-
批准号:10692046
-
项目类别:
-
资助金额:$145.98万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
Immunopathogenesis of SARS-CoV-2 infection
-
批准号:10692253
-
项目类别:
-
资助金额:$1.53万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
Molecular Analysis Of Leukocyte Activation By Chemoattractants
-
批准号:10927745
-
项目类别:
-
资助金额:$246.1万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
Molecular Analysis Of Leukocyte Activation By Chemoattractants
-
批准号:10014044
-
项目类别:
-
资助金额:$264.32万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
Molec Analys Of Neutrophil Activation By Chemoattractant
-
批准号:6985886
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
Molecular Analysis Of Leukocyte Activation By Chemoattractants
-
批准号:10692035
-
项目类别:
-
资助金额:$145.98万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
Molecular Analysis Of Neutrophil Activation By Chemoattr
-
批准号:6822096
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
Molecular Analysis Of Leukocyte Activation By Chemoattractants
-
批准号:7592179
-
项目类别:
-
资助金额:$410.25万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
Molecular Analysis Of Leukocyte Activation By Chemoattractants
-
批准号:8555787
-
项目类别:
-
资助金额:$227.7万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
Immunopathogenesis of SARS-CoV-2 infection
-
批准号:10272295
-
项目类别:
-
资助金额:$1.12万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
Molecular Analysis Of Neutrophil Activation By Chemoattr
-
批准号:6506902
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
Functions and Mechanisms of NF-kB Factors and their Regulators
-
批准号:10932747
-
项目类别:
-
资助金额:$33.56万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
Molecular Analysis Of Leukocyte Activation By Chemoattractants
-
批准号:8745323
-
项目类别:
-
资助金额:$220.11万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
Molecular Analysis Of Leukocyte Activation By Chemoattra
-
批准号:7301887
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
MOLECULAR ANALYSIS OF NEUTROPHIL ACTIVATION BY CHEMOATTRACTANTS
-
批准号:6431607
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Philip Murphy
-
依托单位:
海外基金